Natalie Grover, MD
Associate Professor of Medicine
Clinical Director, Cellular Therapy Program
Leader, Cell Therapy POD
Areas of Interest
Lymphoma; Clinical trials; CAR-T; Cellular therapy.
In my clinic, I treat patients with different types of lymphoma, including aggressive and indolent lymphomas. My specific clinical and research interest is in chimeric antigen receptor T-cell (CAR-T) therapy. I lead several CAR-T cell clinical trials in lymphoma and collaborate with our translational researchers to bring these novel therapies to the clinic. I am interested in innovative approaches to improve the efficacy and safety of CAR-T cell therapy as well as investigations of why some patients progress after treatment. I am also involved in multi-center clinical trials and research collaborations with the goal of improving treatment options and quality of life for patients with lymphoma.
Massachusetts Institute of Technology
Case Western Reserve University
University of Virginia
University of North Carolina at Chapel Hill